Pharmaceutical & Medical Bull 3X Direxion (PILL) |
|
15.39 0.52 (3.5%)
|
10-01 09:24 |
|
Open: |
14.92 |
Pre. Close: |
14.87 |
|
High:
|
15.7962 |
Low:
|
14.82 |
|
Volume:
|
22,367 |
Market Cap:
|
0M |
|
|
|
|
PILL was created on 11/15/17 by Direxion. The ETF provides 3x daily exposure to a modified equal weighted index of pharmaceutical companies in the US. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
14.966 - 15.052 |
15.052 - 15.129 |
|
Low:
|
14.453 - 14.546 |
14.546 - 14.631 |
|
Close:
|
14.764 - 14.916 |
14.916 - 15.052 |
|
Technical analysis |
as of: 2020-09-30 4:45:18 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 19.21 One year: 20.94 |
| Support: |
Support1: 14.06 Support2: 11.70 |
| Resistance: |
Resistance1: 16.45 Resistance2: 17.92 |
| Pivot: |
15.89  |
| Moving Average: |
MA(5): 14.80  MA(20): 15.81
MA(100): 15.74 MA(250): 16.97 |
| MACD: |
MACD(12,26): -0.27 Signal(9): -0.08 |
| Stochastic oscillator: |
%K(14,3): 20.35 %D(3): 17.16 |
| RSI: |
RSI(14): 44.07 |
| 52-week: |
High: 29.70 Low: 6.55 Change(%): 30.5 |
| Average Vol(K): |
3-Month: 4067 10-Days: 2879 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.PILL has closed above bottom band by 26.2%. Bollinger Bands are 49% wider than normal. The large width of the bands suggest high volatility as compared to PILL's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Wed, 30 Sep 2020
OXNARD, Calif. – CURE Pharmaceutical Holdings (OTC: CURR) announced its definitive agreement to acquire Sera L - mg Magazine
Wed, 30 Sep 2020
Apollo’s Covis Nears Deal to Buy Amag Pharmaceutical - Bloomberg
Wed, 30 Sep 2020
Gates Foundation, Pharmaceutical Companies Join to Advance Coronavirus Vaccines - U.S. News & World Report
Wed, 30 Sep 2020
North America pharmaceutical continuous manufacturing market is anticipated to reach US$ 1,335.15 million by 2027 from US$ 619.24 million in 2019 - PRNewswire
Wed, 30 Sep 2020
Pharmaceutical manufacturing companies must handle returned drugs better - The Conversation CA
Wed, 30 Sep 2020
PathoQuest Obtains Pharmaceutical Establishment Status From French ANSM - Contract Pharma
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Neutral |
| Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
